Catalyst Crew Technologies Corp. has appointed Dr. Kevin Rodan Levy as Chief Executive Officer, President, Chief Financial Officer, Secretary, Treasurer, and Sole Director, effective February 17, 2026. The leadership transition follows the resignation of the company's prior officers and directors, as disclosed in a Form 8-K filed with the U.S. Securities and Exchange Commission.
Dr. Rodan brings a background that combines clinical medical training with operational leadership and technology experience. Since 2021, he has served as Chief Executive Officer of Grupo Casamed 18 C.A., where he has been involved in healthcare delivery management and organizational development initiatives. He has also led EmpleUp, a technology-focused human capital and recruitment platform. His experience aligns with Catalyst Crew Technologies' strategic transition toward artificial intelligence-enabled healthcare technology solutions.
"I am honored to lead Catalyst Crew Technologies Corp. at this pivotal stage in its evolution," said Dr. Rodan. "Our focus is on disciplined execution of the Company's strategic transition into AI-enabled healthcare solutions, with particular emphasis on scalable platforms that address access and efficiency challenges in emerging markets. We are committed to building a strong operational foundation and advancing initiatives that position the Company for long-term sustainable development."
The company is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. Catalyst Crew Technologies is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination.
Through technology development initiatives, strategic partnerships, and targeted acquisitions, the company is building an integrated healthcare technology platform positioned to address the growing demand for modernized healthcare delivery systems across emerging markets. For more details about the company, visit https://catalystcrewai.com, or access its official filings through the U.S. Securities and Exchange Commission website.
The appointment of a CEO with both healthcare operations and technology experience signals Catalyst Crew Technologies' serious commitment to its AI healthcare transformation strategy. For business and technology leaders, this development represents a case study in how companies are positioning themselves at the intersection of artificial intelligence and healthcare delivery, particularly in underserved markets where technology could dramatically improve access and efficiency.
The company's focus on emerging markets, beginning with Latin America, addresses a significant global challenge: the disparity in healthcare access between developed and developing regions. AI-enabled solutions could potentially bridge this gap by creating scalable platforms that don't require extensive physical infrastructure. However, as a development-stage enterprise that has not generated revenues from its newly announced business direction, the company faces substantial execution risks common to early-stage technology ventures in regulated industries.
For the healthcare technology industry, Catalyst Crew Technologies' strategic direction reflects broader trends toward AI integration in healthcare delivery, particularly in areas like telehealth, remote monitoring, and data analytics. The company's approach of targeting emerging markets represents a potentially significant market opportunity, as these regions often have less entrenched legacy systems and could leapfrog directly to AI-enabled solutions. The leadership transition and strategic focus could influence how other companies approach similar market opportunities at the intersection of artificial intelligence and global healthcare delivery.
